Phase III, Open-label, Randomized, Multi-centre Study of the Effects of Leukocyte Interleukin, Injection (Multikine) plus Standard of Care (Surgery+ Radiotherapy or Surgery + Concurrent Chemoradiotherapy) in Subject with Advance Primary Squamous Cell Carcinoma of Oral Cavity / Soft Palate versus Standard of Care OnlyCEL-SCI Corporation, Protocol number: CS001P3.